ARMGO PHARMA INC has a total of 25 patent applications. Its first patent ever was published in 2007. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and environmental technology are S BIO PTE LTD, BUSCH-PETERSEN JAKOB and GLAXO WELLCOME SPA.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 2 | |
#3 | Brazil | 2 | |
#4 | EAPO (Eurasian Patent Organization) | 2 | |
#5 | South Africa | 2 | |
#6 | Argentina | 1 | |
#7 | Canada | 1 | |
#8 | China | 1 | |
#9 | Cuba | 1 | |
#10 | Ecuador | 1 | |
#11 | EPO (European Patent Office) | 1 | |
#12 | Hong Kong | 1 | |
#13 | Jordan | 1 | |
#14 | Republic of Korea | 1 | |
#15 | Mexico | 1 | |
#16 | Philippines | 1 | |
#17 | Serbia | 1 | |
#18 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Machines | |
#5 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Belvedere Sandro | 20 |
#2 | Yan Jiaming | 18 |
#3 | Deng Shixian | 14 |
#4 | Landry Donald | 13 |
#5 | Webb Yael | 9 |
#6 | Bertrand Marc | 6 |
#7 | Villeneuve Nicole | 5 |
#8 | Marks Andrew R | 4 |
#9 | Sandro Belvedere | 3 |
#10 | Peglion Jean-Louis | 3 |
Publication | Filing date | Title |
---|---|---|
WO2008144483A2 | Agents for treating disorders involving modulation of ryanodine receptors | |
WO2008140592A2 | Radioactively labeled 1,4-benzothiazepines and methods of screening for compounds that bind ryanodine receptors | |
WO2008064264A2 | In vivo methods for identifying and screening compounds that modulate calstabin binding to a ryanodine receptor |